Literature DB >> 25367453

Imaging cardiac amyloidosis: an opportunity for nuclear cardiology.

Sharmila Dorbala1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25367453     DOI: 10.1007/s12350-014-0024-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

1.  Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.

Authors:  Sharmila Dorbala; Divya Vangala; James Semer; Christopher Strader; John R Bruyere; Marcelo F Di Carli; Stephen C Moore; Rodney H Falk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

2.  How to image cardiac amyloidosis.

Authors:  Rodney H Falk; Candida C Quarta; Sharmila Dorbala
Journal:  Circ Cardiovasc Imaging       Date:  2014-05       Impact factor: 7.792

3.  In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET.

Authors:  Gunnar Antoni; Mark Lubberink; Sergio Estrada; Jan Axelsson; Kristina Carlson; Lars Lindsjö; Tanja Kero; Bengt Långström; Sven-Olof Granstam; Sara Rosengren; Ola Vedin; Cecilia Wassberg; Gerhard Wikström; Per Westermark; Jens Sörensen
Journal:  J Nucl Med       Date:  2012-12-13       Impact factor: 10.057

Review 4.  Nuclear imaging modalities for cardiac amyloidosis.

Authors:  Sabahat Bokhari; Reehan Shahzad; Adam Castaño; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2014-02       Impact factor: 5.952

Review 5.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

  5 in total
  1 in total

1.  Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using 18F-Florbetapir PET/CT.

Authors:  Ariana Nodoushani; Mohammed Samir El-Sady; Mi-Ae Park; Gloria L Castilloveitia; Rodney H Falk; Marcelo F Di Carli; Marie Foley Kijewski; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2019-11-22       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.